Federated Hermes, Inc. Dexcom Inc Transaction History

Federated Hermes, Inc.

$43 Billion
Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 80,713 shares of DXCM stock, worth $7.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

80,713

Previous 362,873 77.76%

Holding current value

$7.17 Million

Previous $24.3 Million 74.19%

% of portfolio

0.01%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $18.5 Million - $22.9 Million	-282,160 Reduced 77.76%	80,713 $6.28 Million
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $77.9 Million - $141 Million	-1,217,840 Reduced 77.04%	362,873 $24.3 Million
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $22.6 Million - $28.8 Million	-205,156 Reduced 11.49%	1,580,713 $179 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $41.1 Million - $50.4 Million	-359,837 Reduced 16.77%	1,785,869 $248 Million
Q4 2023 Jan 31, 2024	SELL	$75.49 - $124.16 $14.9 Million - $24.5 Million	-197,117 Reduced 8.41%	2,145,706 $266 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $11 Million - $17.6 Million	-127,498 Reduced 5.16%	2,342,823 $219 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $17.1 Million - $19.9 Million	152,117 Added 6.56%	2,470,321 $317 Million
Q1 2023 May 08, 2023	BUY	$104.0 - $122.92 $13.1 Million - $15.5 Million	125,725 Added 5.73%	2,318,204 $269 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $3.87 Million - $5.59 Million	-45,536 Reduced 2.03%	2,192,479 $248 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $18.1 Million - $22.3 Million	-237,023 Reduced 9.58%	2,238,015 $180 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $126 Million - $246 Million	1,853,903 Added 298.47%	2,475,038 $184 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $16,181 - $22,394	-172 Reduced 0.03%	621,135 $318 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $140,908 - $176,659	-1,085 Reduced 0.17%	621,307 $334 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $3.66 Million - $4.91 Million	34,278 Added 5.83%	622,392 $340 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $22,839 - $30,436	-282 Reduced 0.05%	588,114 $251 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $691,801 - $854,573	8,159 Added 1.41%	588,396 $211 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $603,798 - $808,934	7,741 Added 1.35%	580,237 $215 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $1.27 Million - $1.51 Million	-13,349 Reduced 2.28%	572,496 $236 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $1.74 Million - $2.92 Million	-27,716 Reduced 4.52%	585,845 $238 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $228,722 - $361,965	-4,786 Reduced 0.77%	613,561 $165 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $767,372 - $1.2 Million	20,955 Added 3.51%	618,347 $135 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $235,563 - $290,394	6,630 Added 1.12%	597,392 $89.2 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $17,928 - $25,064	-644 Reduced 0.11%	590,762 $88.5 Million
Q1 2019 May 10, 2019	SELL	$28.07 - $38.18 $699,560 - $951,521	-24,922 Reduced 4.04%	591,406 $70.4 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $4.39 Million - $6.07 Million	162,562 Added 35.83%	616,328 $18.5 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $150,444 - $236,586	-6,443 Reduced 1.4%	453,766 $64.9 Million
Q2 2018 Aug 10, 2018	BUY	$17.54 - $25.22 $3.98 Million - $5.72 Million	226,740 Added 97.12%	460,209 $43.7 Million
Q1 2018 May 09, 2018	BUY	$13.06 - $18.54 $3.05 Million - $4.33 Million	233,469 New	233,469 $17.3 Million

Others Institutions Holding DXCM

# of Institutions

1,079

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Dexcom Inc Transaction History